Skip to main content
Clinical Trials/NCT01924702
NCT01924702
Unknown
Phase 2

Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation (CATS)

Charité Neurocure AG Flöel1 site in 1 country24 target enrollmentJanuary 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Aphasia
Sponsor
Charité Neurocure AG Flöel
Enrollment
24
Locations
1
Primary Endpoint
naming performance
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine if non-invasive electrical brain stimulation can enhance the outcome of intensive language therapy in chronic aphasia.

Detailed Description

Stroke is the leading cause of death and disability worldwide. Given the increasing average lifespan worldwide, the incidence and prevalence of patients with stroke will dramatically increase in the future. One of the most frequent and devastating conditions after stroke is aphasia, which affects language production and comprehension. High-frequent intensive speech-and-language therapy is currently the treatment of choice in chronic aphasia. However, despite its general effectiveness, treatment effect sizes are only low to moderate. Thus, there is a pressing need to explore novel training-adjuvant therapies to enhance treatment efficacy. Moreover, very little is known about the neurobiology of treatment-induced recovery in chronic aphasia. This is the prerequisite to improve existing and/or develop new treatment paradigms. Thus, in the present project the investigators aim to assess whether the outcome of intensive language training can be enhanced by adjuvant non-invasive brain stimulation. They will be using anodal transcranial direct current stimulation (atDCS) that has previously been shown to enhance (a) language and motor learning in healthy subjects and (b) motor recovery in stroke patients. Specifically, in a longitudinal group comparison design, two matched groups of patients with chronic anomia will receive two weeks of intensive language training with or without atDCS. Treatment effects will be assessed immediately after the two week intervention period and several months after the end of the training. The Investigators will also use functional and structural magnetic resonance imaging (MRI) to elucidate language network changes in the two groups.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
December 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Charité Neurocure AG Flöel
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • chronic stroke (\> 1 year after event)
  • aphasia due to stroke with naming impairment
  • German as first language
  • first-ever stroke

Exclusion Criteria

  • more than 1 stroke
  • history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity
  • contraindications for Magnetic Resonance Imaging or transcranial direct current stimulation

Outcomes

Primary Outcomes

naming performance

Time Frame: Change of naming score from baseline (day 1 of study) to immediately after 2-week intervention period (post-testing)

Secondary Outcomes

  • Naming performance during functional magnetic resonance imaging(Change of naming score from post-testing (after end of intervention) to 3 months after the intervention (follow-up))
  • Changes on the Amsterdam Nijmegen Everyday Language Test (ANELT)(Change of naming score from post-testing (after end of intervention) to 3 months after the intervention (follow-up))
  • Naming performance during functional magnetic resonance scanning(Change of naming score from baseline (day 1 of study) to immediately after 2-week intervention period (post-testing))
  • naming performance(Change of naming score from post-testing (after end of intervention) to 3 months after the intervention (follow-up))

Study Sites (1)

Loading locations...

Similar Trials